PlainRecalls
FDA Drug Moderate Class II Terminated

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01

Reported: August 24, 2022 Initiated: August 10, 2022 #D-1354-2022

Product Description

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01

Reason for Recall

cGMP Deviations: deviations leading to potential cross-contamination.

Details

Recalling Firm
Nephron Sc Inc
Units Affected
5040 vials
Distribution
USA Nationwide
Location
West Columbia, SC

Frequently Asked Questions

What product was recalled?
Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01. Recalled by Nephron Sc Inc. Units affected: 5040 vials.
Why was this product recalled?
cGMP Deviations: deviations leading to potential cross-contamination.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 24, 2022. Severity: Moderate. Recall number: D-1354-2022.